[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global OTC Cold and Cough Medicines Market Growth 2024-2030

June 2024 | 109 pages | ID: G1C6BD902E64EN
LP Information

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The report requires updating with new data and is sent in 48 hours after order is placed.

According to our LPI (LP Information) latest study, the global OTC Cold and Cough Medicines market size was valued at US$ million in 2023. With growing demand in downstream market, the OTC Cold and Cough Medicines is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.

The research report highlights the growth potential of the global OTC Cold and Cough Medicines market. OTC Cold and Cough Medicines are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of OTC Cold and Cough Medicines. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the OTC Cold and Cough Medicines market.

Over-the-counter (OTC) drugs are medicines sold directly to a consumer without a requirement for a prescription from a healthcare professional, as opposed to prescription drugs, which may be supplied only to consumers possessing a valid prescription. The drugs for the treatment of cold and cough acts on the receptors to which the virus causing the infection gets attached to, by antagonizing the action of the receptors and killing the viral infection, thereby reducing congestion by lysing the mucus and dilating the bronchioles constricted by the mucus deposition. Cold weather is not directly associated with common cold, but the virus which causes common cold, called rhinovirus, is responsible for all cold related illnesses. Once the virus is inhaled, it attaches to the cells in nasal passages.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Key Features:

The report on OTC Cold and Cough Medicines market reflects various aspects and provide valuable insights into the industry.

Market Size and Growth: The research report provide an overview of the current size and growth of the OTC Cold and Cough Medicines market. It may include historical data, market segmentation by Type (e.g., Pellets, Drops), and regional breakdowns.

Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the OTC Cold and Cough Medicines market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.

Competitive Landscape: The research report provides analysis of the competitive landscape within the OTC Cold and Cough Medicines market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.

Technological Developments: The research report can delve into the latest technological developments in the OTC Cold and Cough Medicines industry. This include advancements in OTC Cold and Cough Medicines technology, OTC Cold and Cough Medicines new entrants, OTC Cold and Cough Medicines new investment, and other innovations that are shaping the future of OTC Cold and Cough Medicines.

Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the OTC Cold and Cough Medicines market. It includes factors influencing customer ' purchasing decisions, preferences for OTC Cold and Cough Medicines product.

Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the OTC Cold and Cough Medicines market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting OTC Cold and Cough Medicines market. The report also evaluates the effectiveness of these policies in driving market growth.

Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the OTC Cold and Cough Medicines market.

Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the OTC Cold and Cough Medicines industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.

Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the OTC Cold and Cough Medicines market.

Market Segmentation:

OTC Cold and Cough Medicines market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.

Segmentation by type
  • Pellets
  • Drops
  • Tablets
  • Capsules
  • Powders
  • Sprays
Segmentation by application
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
This report also splits the market by region:
  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
  • Sanofi-Aventis
  • Johnson & Johnson
  • Reckitt Benckiser Group Plc.
  • Novartis AG
  • GlaxoSmithKline Plc.
  • AstraZeneca Plc.
  • Pfizer Inc.
  • Sun Pharmaceutical
  • Prestige Brands Holdings, Inc.
  • Procter & Gamble Co.
Key Questions Addressed in this Report

What is the 10-year outlook for the global OTC Cold and Cough Medicines market?

What factors are driving OTC Cold and Cough Medicines market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do OTC Cold and Cough Medicines market opportunities vary by end market size?

How does OTC Cold and Cough Medicines break out type, application?
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global OTC Cold and Cough Medicines Annual Sales 2019-2030
  2.1.2 World Current & Future Analysis for OTC Cold and Cough Medicines by Geographic Region, 2019, 2023 & 2030
  2.1.3 World Current & Future Analysis for OTC Cold and Cough Medicines by Country/Region, 2019, 2023 & 2030
2.2 OTC Cold and Cough Medicines Segment by Type
  2.2.1 Pellets
  2.2.2 Drops
  2.2.3 Tablets
  2.2.4 Capsules
  2.2.5 Powders
  2.2.6 Sprays
2.3 OTC Cold and Cough Medicines Sales by Type
  2.3.1 Global OTC Cold and Cough Medicines Sales Market Share by Type (2019-2024)
  2.3.2 Global OTC Cold and Cough Medicines Revenue and Market Share by Type (2019-2024)
  2.3.3 Global OTC Cold and Cough Medicines Sale Price by Type (2019-2024)
2.4 OTC Cold and Cough Medicines Segment by Application
  2.4.1 Hospital Pharmacies
  2.4.2 Retail Pharmacies
  2.4.3 Online Pharmacies
2.5 OTC Cold and Cough Medicines Sales by Application
  2.5.1 Global OTC Cold and Cough Medicines Sale Market Share by Application (2019-2024)
  2.5.2 Global OTC Cold and Cough Medicines Revenue and Market Share by Application (2019-2024)
  2.5.3 Global OTC Cold and Cough Medicines Sale Price by Application (2019-2024)

3 GLOBAL OTC COLD AND COUGH MEDICINES BY COMPANY

3.1 Global OTC Cold and Cough Medicines Breakdown Data by Company
  3.1.1 Global OTC Cold and Cough Medicines Annual Sales by Company (2019-2024)
  3.1.2 Global OTC Cold and Cough Medicines Sales Market Share by Company (2019-2024)
3.2 Global OTC Cold and Cough Medicines Annual Revenue by Company (2019-2024)
  3.2.1 Global OTC Cold and Cough Medicines Revenue by Company (2019-2024)
  3.2.2 Global OTC Cold and Cough Medicines Revenue Market Share by Company (2019-2024)
3.3 Global OTC Cold and Cough Medicines Sale Price by Company
3.4 Key Manufacturers OTC Cold and Cough Medicines Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers OTC Cold and Cough Medicines Product Location Distribution
  3.4.2 Players OTC Cold and Cough Medicines Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 WORLD HISTORIC REVIEW FOR OTC COLD AND COUGH MEDICINES BY GEOGRAPHIC REGION

4.1 World Historic OTC Cold and Cough Medicines Market Size by Geographic Region (2019-2024)
  4.1.1 Global OTC Cold and Cough Medicines Annual Sales by Geographic Region (2019-2024)
  4.1.2 Global OTC Cold and Cough Medicines Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic OTC Cold and Cough Medicines Market Size by Country/Region (2019-2024)
  4.2.1 Global OTC Cold and Cough Medicines Annual Sales by Country/Region (2019-2024)
  4.2.2 Global OTC Cold and Cough Medicines Annual Revenue by Country/Region (2019-2024)
4.3 Americas OTC Cold and Cough Medicines Sales Growth
4.4 APAC OTC Cold and Cough Medicines Sales Growth
4.5 Europe OTC Cold and Cough Medicines Sales Growth
4.6 Middle East & Africa OTC Cold and Cough Medicines Sales Growth

5 AMERICAS

5.1 Americas OTC Cold and Cough Medicines Sales by Country
  5.1.1 Americas OTC Cold and Cough Medicines Sales by Country (2019-2024)
  5.1.2 Americas OTC Cold and Cough Medicines Revenue by Country (2019-2024)
5.2 Americas OTC Cold and Cough Medicines Sales by Type
5.3 Americas OTC Cold and Cough Medicines Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC OTC Cold and Cough Medicines Sales by Region
  6.1.1 APAC OTC Cold and Cough Medicines Sales by Region (2019-2024)
  6.1.2 APAC OTC Cold and Cough Medicines Revenue by Region (2019-2024)
6.2 APAC OTC Cold and Cough Medicines Sales by Type
6.3 APAC OTC Cold and Cough Medicines Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe OTC Cold and Cough Medicines by Country
  7.1.1 Europe OTC Cold and Cough Medicines Sales by Country (2019-2024)
  7.1.2 Europe OTC Cold and Cough Medicines Revenue by Country (2019-2024)
7.2 Europe OTC Cold and Cough Medicines Sales by Type
7.3 Europe OTC Cold and Cough Medicines Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa OTC Cold and Cough Medicines by Country
  8.1.1 Middle East & Africa OTC Cold and Cough Medicines Sales by Country (2019-2024)
  8.1.2 Middle East & Africa OTC Cold and Cough Medicines Revenue by Country (2019-2024)
8.2 Middle East & Africa OTC Cold and Cough Medicines Sales by Type
8.3 Middle East & Africa OTC Cold and Cough Medicines Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of OTC Cold and Cough Medicines
10.3 Manufacturing Process Analysis of OTC Cold and Cough Medicines
10.4 Industry Chain Structure of OTC Cold and Cough Medicines

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 OTC Cold and Cough Medicines Distributors
11.3 OTC Cold and Cough Medicines Customer

12 WORLD FORECAST REVIEW FOR OTC COLD AND COUGH MEDICINES BY GEOGRAPHIC REGION

12.1 Global OTC Cold and Cough Medicines Market Size Forecast by Region
  12.1.1 Global OTC Cold and Cough Medicines Forecast by Region (2025-2030)
  12.1.2 Global OTC Cold and Cough Medicines Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global OTC Cold and Cough Medicines Forecast by Type
12.7 Global OTC Cold and Cough Medicines Forecast by Application

13 KEY PLAYERS ANALYSIS

13.1 Sanofi-Aventis
  13.1.1 Sanofi-Aventis Company Information
  13.1.2 Sanofi-Aventis OTC Cold and Cough Medicines Product Portfolios and Specifications
  13.1.3 Sanofi-Aventis OTC Cold and Cough Medicines Sales, Revenue, Price and Gross Margin (2019-2024)
  13.1.4 Sanofi-Aventis Main Business Overview
  13.1.5 Sanofi-Aventis Latest Developments
13.2 Johnson & Johnson
  13.2.1 Johnson & Johnson Company Information
  13.2.2 Johnson & Johnson OTC Cold and Cough Medicines Product Portfolios and Specifications
  13.2.3 Johnson & Johnson OTC Cold and Cough Medicines Sales, Revenue, Price and Gross Margin (2019-2024)
  13.2.4 Johnson & Johnson Main Business Overview
  13.2.5 Johnson & Johnson Latest Developments
13.3 Reckitt Benckiser Group Plc.
  13.3.1 Reckitt Benckiser Group Plc. Company Information
  13.3.2 Reckitt Benckiser Group Plc. OTC Cold and Cough Medicines Product Portfolios and Specifications
  13.3.3 Reckitt Benckiser Group Plc. OTC Cold and Cough Medicines Sales, Revenue, Price and Gross Margin (2019-2024)
  13.3.4 Reckitt Benckiser Group Plc. Main Business Overview
  13.3.5 Reckitt Benckiser Group Plc. Latest Developments
13.4 Novartis AG
  13.4.1 Novartis AG Company Information
  13.4.2 Novartis AG OTC Cold and Cough Medicines Product Portfolios and Specifications
  13.4.3 Novartis AG OTC Cold and Cough Medicines Sales, Revenue, Price and Gross Margin (2019-2024)
  13.4.4 Novartis AG Main Business Overview
  13.4.5 Novartis AG Latest Developments
13.5 GlaxoSmithKline Plc.
  13.5.1 GlaxoSmithKline Plc. Company Information
  13.5.2 GlaxoSmithKline Plc. OTC Cold and Cough Medicines Product Portfolios and Specifications
  13.5.3 GlaxoSmithKline Plc. OTC Cold and Cough Medicines Sales, Revenue, Price and Gross Margin (2019-2024)
  13.5.4 GlaxoSmithKline Plc. Main Business Overview
  13.5.5 GlaxoSmithKline Plc. Latest Developments
13.6 AstraZeneca Plc.
  13.6.1 AstraZeneca Plc. Company Information
  13.6.2 AstraZeneca Plc. OTC Cold and Cough Medicines Product Portfolios and Specifications
  13.6.3 AstraZeneca Plc. OTC Cold and Cough Medicines Sales, Revenue, Price and Gross Margin (2019-2024)
  13.6.4 AstraZeneca Plc. Main Business Overview
  13.6.5 AstraZeneca Plc. Latest Developments
13.7 Pfizer Inc.
  13.7.1 Pfizer Inc. Company Information
  13.7.2 Pfizer Inc. OTC Cold and Cough Medicines Product Portfolios and Specifications
  13.7.3 Pfizer Inc. OTC Cold and Cough Medicines Sales, Revenue, Price and Gross Margin (2019-2024)
  13.7.4 Pfizer Inc. Main Business Overview
  13.7.5 Pfizer Inc. Latest Developments
13.8 Sun Pharmaceutical
  13.8.1 Sun Pharmaceutical Company Information
  13.8.2 Sun Pharmaceutical OTC Cold and Cough Medicines Product Portfolios and Specifications
  13.8.3 Sun Pharmaceutical OTC Cold and Cough Medicines Sales, Revenue, Price and Gross Margin (2019-2024)
  13.8.4 Sun Pharmaceutical Main Business Overview
  13.8.5 Sun Pharmaceutical Latest Developments
13.9 Prestige Brands Holdings, Inc.
  13.9.1 Prestige Brands Holdings, Inc. Company Information
  13.9.2 Prestige Brands Holdings, Inc. OTC Cold and Cough Medicines Product Portfolios and Specifications
  13.9.3 Prestige Brands Holdings, Inc. OTC Cold and Cough Medicines Sales, Revenue, Price and Gross Margin (2019-2024)
  13.9.4 Prestige Brands Holdings, Inc. Main Business Overview
  13.9.5 Prestige Brands Holdings, Inc. Latest Developments
13.10 Procter & Gamble Co.
  13.10.1 Procter & Gamble Co. Company Information
  13.10.2 Procter & Gamble Co. OTC Cold and Cough Medicines Product Portfolios and Specifications
  13.10.3 Procter & Gamble Co. OTC Cold and Cough Medicines Sales, Revenue, Price and Gross Margin (2019-2024)
  13.10.4 Procter & Gamble Co. Main Business Overview
  13.10.5 Procter & Gamble Co. Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION


LIST OF TABLES

Table 1. OTC Cold and Cough Medicines Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. OTC Cold and Cough Medicines Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Pellets
Table 4. Major Players of Drops
Table 5. Major Players of Tablets
Table 6. Major Players of Capsules
Table 7. Major Players of Powders
Table 8. Major Players of Sprays
Table 9. Global OTC Cold and Cough Medicines Sales by Type (2019-2024) & (K Units)
Table 10. Global OTC Cold and Cough Medicines Sales Market Share by Type (2019-2024)
Table 11. Global OTC Cold and Cough Medicines Revenue by Type (2019-2024) & ($ million)
Table 12. Global OTC Cold and Cough Medicines Revenue Market Share by Type (2019-2024)
Table 13. Global OTC Cold and Cough Medicines Sale Price by Type (2019-2024) & (US$/Unit)
Table 14. Global OTC Cold and Cough Medicines Sales by Application (2019-2024) & (K Units)
Table 15. Global OTC Cold and Cough Medicines Sales Market Share by Application (2019-2024)
Table 16. Global OTC Cold and Cough Medicines Revenue by Application (2019-2024)
Table 17. Global OTC Cold and Cough Medicines Revenue Market Share by Application (2019-2024)
Table 18. Global OTC Cold and Cough Medicines Sale Price by Application (2019-2024) & (US$/Unit)
Table 19. Global OTC Cold and Cough Medicines Sales by Company (2019-2024) & (K Units)
Table 20. Global OTC Cold and Cough Medicines Sales Market Share by Company (2019-2024)
Table 21. Global OTC Cold and Cough Medicines Revenue by Company (2019-2024) ($ Millions)
Table 22. Global OTC Cold and Cough Medicines Revenue Market Share by Company (2019-2024)
Table 23. Global OTC Cold and Cough Medicines Sale Price by Company (2019-2024) & (US$/Unit)
Table 24. Key Manufacturers OTC Cold and Cough Medicines Producing Area Distribution and Sales Area
Table 25. Players OTC Cold and Cough Medicines Products Offered
Table 26. OTC Cold and Cough Medicines Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 27. New Products and Potential Entrants
Table 28. Mergers & Acquisitions, Expansion
Table 29. Global OTC Cold and Cough Medicines Sales by Geographic Region (2019-2024) & (K Units)
Table 30. Global OTC Cold and Cough Medicines Sales Market Share Geographic Region (2019-2024)
Table 31. Global OTC Cold and Cough Medicines Revenue by Geographic Region (2019-2024) & ($ millions)
Table 32. Global OTC Cold and Cough Medicines Revenue Market Share by Geographic Region (2019-2024)
Table 33. Global OTC Cold and Cough Medicines Sales by Country/Region (2019-2024) & (K Units)
Table 34. Global OTC Cold and Cough Medicines Sales Market Share by Country/Region (2019-2024)
Table 35. Global OTC Cold and Cough Medicines Revenue by Country/Region (2019-2024) & ($ millions)
Table 36. Global OTC Cold and Cough Medicines Revenue Market Share by Country/Region (2019-2024)
Table 37. Americas OTC Cold and Cough Medicines Sales by Country (2019-2024) & (K Units)
Table 38. Americas OTC Cold and Cough Medicines Sales Market Share by Country (2019-2024)
Table 39. Americas OTC Cold and Cough Medicines Revenue by Country (2019-2024) & ($ Millions)
Table 40. Americas OTC Cold and Cough Medicines Revenue Market Share by Country (2019-2024)
Table 41. Americas OTC Cold and Cough Medicines Sales by Type (2019-2024) & (K Units)
Table 42. Americas OTC Cold and Cough Medicines Sales by Application (2019-2024) & (K Units)
Table 43. APAC OTC Cold and Cough Medicines Sales by Region (2019-2024) & (K Units)
Table 44. APAC OTC Cold and Cough Medicines Sales Market Share by Region (2019-2024)
Table 45. APAC OTC Cold and Cough Medicines Revenue by Region (2019-2024) & ($ Millions)
Table 46. APAC OTC Cold and Cough Medicines Revenue Market Share by Region (2019-2024)
Table 47. APAC OTC Cold and Cough Medicines Sales by Type (2019-2024) & (K Units)
Table 48. APAC OTC Cold and Cough Medicines Sales by Application (2019-2024) & (K Units)
Table 49. Europe OTC Cold and Cough Medicines Sales by Country (2019-2024) & (K Units)
Table 50. Europe OTC Cold and Cough Medicines Sales Market Share by Country (2019-2024)
Table 51. Europe OTC Cold and Cough Medicines Revenue by Country (2019-2024) & ($ Millions)
Table 52. Europe OTC Cold and Cough Medicines Revenue Market Share by Country (2019-2024)
Table 53. Europe OTC Cold and Cough Medicines Sales by Type (2019-2024) & (K Units)
Table 54. Europe OTC Cold and Cough Medicines Sales by Application (2019-2024) & (K Units)
Table 55. Middle East & Africa OTC Cold and Cough Medicines Sales by Country (2019-2024) & (K Units)
Table 56. Middle East & Africa OTC Cold and Cough Medicines Sales Market Share by Country (2019-2024)
Table 57. Middle East & Africa OTC Cold and Cough Medicines Revenue by Country (2019-2024) & ($ Millions)
Table 58. Middle East & Africa OTC Cold and Cough Medicines Revenue Market Share by Country (2019-2024)
Table 59. Middle East & Africa OTC Cold and Cough Medicines Sales by Type (2019-2024) & (K Units)
Table 60. Middle East & Africa OTC Cold and Cough Medicines Sales by Application (2019-2024) & (K Units)
Table 61. Key Market Drivers & Growth Opportunities of OTC Cold and Cough Medicines
Table 62. Key Market Challenges & Risks of OTC Cold and Cough Medicines
Table 63. Key Industry Trends of OTC Cold and Cough Medicines
Table 64. OTC Cold and Cough Medicines Raw Material
Table 65. Key Suppliers of Raw Materials
Table 66. OTC Cold and Cough Medicines Distributors List
Table 67. OTC Cold and Cough Medicines Customer List
Table 68. Global OTC Cold and Cough Medicines Sales Forecast by Region (2025-2030) & (K Units)
Table 69. Global OTC Cold and Cough Medicines Revenue Forecast by Region (2025-2030) & ($ millions)
Table 70. Americas OTC Cold and Cough Medicines Sales Forecast by Country (2025-2030) & (K Units)
Table 71. Americas OTC Cold and Cough Medicines Revenue Forecast by Country (2025-2030) & ($ millions)
Table 72. APAC OTC Cold and Cough Medicines Sales Forecast by Region (2025-2030) & (K Units)
Table 73. APAC OTC Cold and Cough Medicines Revenue Forecast by Region (2025-2030) & ($ millions)
Table 74. Europe OTC Cold and Cough Medicines Sales Forecast by Country (2025-2030) & (K Units)
Table 75. Europe OTC Cold and Cough Medicines Revenue Forecast by Country (2025-2030) & ($ millions)
Table 76. Middle East & Africa OTC Cold and Cough Medicines Sales Forecast by Country (2025-2030) & (K Units)
Table 77. Middle East & Africa OTC Cold and Cough Medicines Revenue Forecast by Country (2025-2030) & ($ millions)
Table 78. Global OTC Cold and Cough Medicines Sales Forecast by Type (2025-2030) & (K Units)
Table 79. Global OTC Cold and Cough Medicines Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 80. Global OTC Cold and Cough Medicines Sales Forecast by Application (2025-2030) & (K Units)
Table 81. Global OTC Cold and Cough Medicines Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 82. Sanofi-Aventis Basic Information, OTC Cold and Cough Medicines Manufacturing Base, Sales Area and Its Competitors
Table 83. Sanofi-Aventis OTC Cold and Cough Medicines Product Portfolios and Specifications
Table 84. Sanofi-Aventis OTC Cold and Cough Medicines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 85. Sanofi-Aventis Main Business
Table 86. Sanofi-Aventis Latest Developments
Table 87. Johnson & Johnson Basic Information, OTC Cold and Cough Medicines Manufacturing Base, Sales Area and Its Competitors
Table 88. Johnson & Johnson OTC Cold and Cough Medicines Product Portfolios and Specifications
Table 89. Johnson & Johnson OTC Cold and Cough Medicines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 90. Johnson & Johnson Main Business
Table 91. Johnson & Johnson Latest Developments
Table 92. Reckitt Benckiser Group Plc. Basic Information, OTC Cold and Cough Medicines Manufacturing Base, Sales Area and Its Competitors
Table 93. Reckitt Benckiser Group Plc. OTC Cold and Cough Medicines Product Portfolios and Specifications
Table 94. Reckitt Benckiser Group Plc. OTC Cold and Cough Medicines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 95. Reckitt Benckiser Group Plc. Main Business
Table 96. Reckitt Benckiser Group Plc. Latest Developments
Table 97. Novartis AG Basic Information, OTC Cold and Cough Medicines Manufacturing Base, Sales Area and Its Competitors
Table 98. Novartis AG OTC Cold and Cough Medicines Product Portfolios and Specifications
Table 99. Novartis AG OTC Cold and Cough Medicines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 100. Novartis AG Main Business
Table 101. Novartis AG Latest Developments
Table 102. GlaxoSmithKline Plc. Basic Information, OTC Cold and Cough Medicines Manufacturing Base, Sales Area and Its Competitors
Table 103. GlaxoSmithKline Plc. OTC Cold and Cough Medicines Product Portfolios and Specifications
Table 104. GlaxoSmithKline Plc. OTC Cold and Cough Medicines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 105. GlaxoSmithKline Plc. Main Business
Table 106. GlaxoSmithKline Plc. Latest Developments
Table 107. AstraZeneca Plc. Basic Information, OTC Cold and Cough Medicines Manufacturing Base, Sales Area and Its Competitors
Table 108. AstraZeneca Plc. OTC Cold and Cough Medicines Product Portfolios and Specifications
Table 109. AstraZeneca Plc. OTC Cold and Cough Medicines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 110. AstraZeneca Plc. Main Business
Table 111. AstraZeneca Plc. Latest Developments
Table 112. Pfizer Inc. Basic Information, OTC Cold and Cough Medicines Manufacturing Base, Sales Area and Its Competitors
Table 113. Pfizer Inc. OTC Cold and Cough Medicines Product Portfolios and Specifications
Table 114. Pfizer Inc. OTC Cold and Cough Medicines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 115. Pfizer Inc. Main Business
Table 116. Pfizer Inc. Latest Developments
Table 117. Sun Pharmaceutical Basic Information, OTC Cold and Cough Medicines Manufacturing Base, Sales Area and Its Competitors
Table 118. Sun Pharmaceutical OTC Cold and Cough Medicines Product Portfolios and Specifications
Table 119. Sun Pharmaceutical OTC Cold and Cough Medicines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 120. Sun Pharmaceutical Main Business
Table 121. Sun Pharmaceutical Latest Developments
Table 122. Prestige Brands Holdings, Inc. Basic Information, OTC Cold and Cough Medicines Manufacturing Base, Sales Area and Its Competitors
Table 123. Prestige Brands Holdings, Inc. OTC Cold and Cough Medicines Product Portfolios and Specifications
Table 124. Prestige Brands Holdings, Inc. OTC Cold and Cough Medicines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 125. Prestige Brands Holdings, Inc. Main Business
Table 126. Prestige Brands Holdings, Inc. Latest Developments
Table 127. Procter & Gamble Co. Basic Information, OTC Cold and Cough Medicines Manufacturing Base, Sales Area and Its Competitors
Table 128. Procter & Gamble Co. OTC Cold and Cough Medicines Product Portfolios and Specifications
Table 129. Procter & Gamble Co. OTC Cold and Cough Medicines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 130. Procter & Gamble Co. Main Business
Table 131. Procter & Gamble Co. Latest Developments

LIST OF FIGURES

Figure 1. Picture of OTC Cold and Cough Medicines
Figure 2. OTC Cold and Cough Medicines Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global OTC Cold and Cough Medicines Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global OTC Cold and Cough Medicines Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. OTC Cold and Cough Medicines Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of Pellets
Figure 10. Product Picture of Drops
Figure 11. Product Picture of Tablets
Figure 12. Product Picture of Capsules
Figure 13. Product Picture of Powders
Figure 14. Product Picture of Sprays
Figure 15. Global OTC Cold and Cough Medicines Sales Market Share by Type in 2023
Figure 16. Global OTC Cold and Cough Medicines Revenue Market Share by Type (2019-2024)
Figure 17. OTC Cold and Cough Medicines Consumed in Hospital Pharmacies
Figure 18. Global OTC Cold and Cough Medicines Market: Hospital Pharmacies (2019-2024) & (K Units)
Figure 19. OTC Cold and Cough Medicines Consumed in Retail Pharmacies
Figure 20. Global OTC Cold and Cough Medicines Market: Retail Pharmacies (2019-2024) & (K Units)
Figure 21. OTC Cold and Cough Medicines Consumed in Online Pharmacies
Figure 22. Global OTC Cold and Cough Medicines Market: Online Pharmacies (2019-2024) & (K Units)
Figure 23. Global OTC Cold and Cough Medicines Sales Market Share by Application (2023)
Figure 24. Global OTC Cold and Cough Medicines Revenue Market Share by Application in 2023
Figure 25. OTC Cold and Cough Medicines Sales Market by Company in 2023 (K Units)
Figure 26. Global OTC Cold and Cough Medicines Sales Market Share by Company in 2023
Figure 27. OTC Cold and Cough Medicines Revenue Market by Company in 2023 ($ Million)
Figure 28. Global OTC Cold and Cough Medicines Revenue Market Share by Company in 2023
Figure 29. Global OTC Cold and Cough Medicines Sales Market Share by Geographic Region (2019-2024)
Figure 30. Global OTC Cold and Cough Medicines Revenue Market Share by Geographic Region in 2023
Figure 31. Americas OTC Cold and Cough Medicines Sales 2019-2024 (K Units)
Figure 32. Americas OTC Cold and Cough Medicines Revenue 2019-2024 ($ Millions)
Figure 33. APAC OTC Cold and Cough Medicines Sales 2019-2024 (K Units)
Figure 34. APAC OTC Cold and Cough Medicines Revenue 2019-2024 ($ Millions)
Figure 35. Europe OTC Cold and Cough Medicines Sales 2019-2024 (K Units)
Figure 36. Europe OTC Cold and Cough Medicines Revenue 2019-2024 ($ Millions)
Figure 37. Middle East & Africa OTC Cold and Cough Medicines Sales 2019-2024 (K Units)
Figure 38. Middle East & Africa OTC Cold and Cough Medicines Revenue 2019-2024 ($ Millions)
Figure 39. Americas OTC Cold and Cough Medicines Sales Market Share by Country in 2023
Figure 40. Americas OTC Cold and Cough Medicines Revenue Market Share by Country in 2023
Figure 41. Americas OTC Cold and Cough Medicines Sales Market Share by Type (2019-2024)
Figure 42. Americas OTC Cold and Cough Medicines Sales Market Share by Application (2019-2024)
Figure 43. United States OTC Cold and Cough Medicines Revenue Growth 2019-2024 ($ Millions)
Figure 44. Canada OTC Cold and Cough Medicines Revenue Growth 2019-2024 ($ Millions)
Figure 45. Mexico OTC Cold and Cough Medicines Revenue Growth 2019-2024 ($ Millions)
Figure 46. Brazil OTC Cold and Cough Medicines Revenue Growth 2019-2024 ($ Millions)
Figure 47. APAC OTC Cold and Cough Medicines Sales Market Share by Region in 2023
Figure 48. APAC OTC Cold and Cough Medicines Revenue Market Share by Regions in 2023
Figure 49. APAC OTC Cold and Cough Medicines Sales Market Share by Type (2019-2024)
Figure 50. APAC OTC Cold and Cough Medicines Sales Market Share by Application (2019-2024)
Figure 51. China OTC Cold and Cough Medicines Revenue Growth 2019-2024 ($ Millions)
Figure 52. Japan OTC Cold and Cough Medicines Revenue Growth 2019-2024 ($ Millions)
Figure 53. South Korea OTC Cold and Cough Medicines Revenue Growth 2019-2024 ($ Millions)
Figure 54. Southeast Asia OTC Cold and Cough Medicines Revenue Growth 2019-2024 ($ Millions)
Figure 55. India OTC Cold and Cough Medicines Revenue Growth 2019-2024 ($ Millions)
Figure 56. Australia OTC Cold and Cough Medicines Revenue Growth 2019-2024 ($ Millions)
Figure 57. China Taiwan OTC Cold and Cough Medicines Revenue Growth 2019-2024 ($ Millions)
Figure 58. Europe OTC Cold and Cough Medicines Sales Market Share by Country in 2023
Figure 59. Europe OTC Cold and Cough Medicines Revenue Market Share by Country in 2023
Figure 60. Europe OTC Cold and Cough Medicines Sales Market Share by Type (2019-2024)
Figure 61. Europe OTC Cold and Cough Medicines Sales Market Share by Application (2019-2024)
Figure 62. Germany OTC Cold and Cough Medicines Revenue Growth 2019-2024 ($ Millions)
Figure 63. France OTC Cold and Cough Medicines Revenue Growth 2019-2024 ($ Millions)
Figure 64. UK OTC Cold and Cough Medicines Revenue Growth 2019-2024 ($ Millions)
Figure 65. Italy OTC Cold and Cough Medicines Revenue Growth 2019-2024 ($ Millions)
Figure 66. Russia OTC Cold and Cough Medicines Revenue Growth 2019-2024 ($ Millions)
Figure 67. Middle East & Africa OTC Cold and Cough Medicines Sales Market Share by Country in 2023
Figure 68. Middle East & Africa OTC Cold and Cough Medicines Revenue Market Share by Country in 2023
Figure 69. Middle East & Africa OTC Cold and Cough Medicines Sales Market Share by Type (2019-2024)
Figure 70. Middle East & Africa OTC Cold and Cough Medicines Sales Market Share by Application (2019-2024)
Figure 71. Egypt OTC Cold and Cough Medicines Revenue Growth 2019-2024 ($ Millions)
Figure 72. South Africa OTC Cold and Cough Medicines Revenue Growth 2019-2024 ($ Millions)
Figure 73. Israel OTC Cold and Cough Medicines Revenue Growth 2019-2024 ($ Millions)
Figure 74. Turkey OTC Cold and Cough Medicines Revenue Growth 2019-2024 ($ Millions)
Figure 75. GCC Country OTC Cold and Cough Medicines Revenue Growth 2019-2024 ($ Millions)
Figure 76. Manufacturing Cost Structure Analysis of OTC Cold and Cough Medicines in 2023
Figure 77. Manufacturing Process Analysis of OTC Cold and Cough Medicines
Figure 78. Industry Chain Structure of OTC Cold and Cough Medicines
Figure 79. Channels of Distribution
Figure 80. Global OTC Cold and Cough Medicines Sales Market Forecast by Region (2025-2030)
Figure 81. Global OTC Cold and Cough Medicines Revenue Market Share Forecast by Region (2025-2030)
Figure 82. Global OTC Cold and Cough Medicines Sales Market Share Forecast by Type (2025-2030)
Figure 83. Global OTC Cold and Cough Medicines Revenue Market Share Forecast by Type (2025-2030)
Figure 84. Global OTC Cold and Cough Medicines Sales Market Share Forecast by Application (2025-2030)
Figure 85. Global OTC Cold and Cough Medicines Revenue Market Share Forecast by Application (2025-2030)


More Publications